Journal of The Japan Organization of Clinical Dermatologists最新文献_第7页

Which drug do you choose to treat various symptoms of acne vulgaris? (second report) - a proposal for cases in which initial treatment was not successful - 你会选择哪种药物来治疗寻常痤疮的各种症状?(第二次报告)-针对初步治疗不成功的病例的建议-

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.46

M. Kawashima, I. Kurokawa, Nobukazu Hayashi, Masako Watanabe, M. Tanioka

引用次数: 0

The Effects of Pine Bark Extract (Flavangenol®) on the Clinical Treatment and Serum Lipid Levels of Patients with Psoriasis 松皮提取物(黄烷醇®)对银屑病患者临床治疗及血脂水平的影响

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.731

S. Imafuku, Bunji Koga, K. Itou, H. Ihara, T. Kamiya, Kinya Takagaki, Nobutaka Kusaba

{"title":"The Effects of Pine Bark Extract (Flavangenol®) on the Clinical Treatment and Serum Lipid Levels of Patients with Psoriasis","authors":"S. Imafuku, Bunji Koga, K. Itou, H. Ihara, T. Kamiya, Kinya Takagaki, Nobutaka Kusaba","doi":"10.3812/jocd.36.731","DOIUrl":"https://doi.org/10.3812/jocd.36.731","url":null,"abstract":"Psoriasis is a chronic inflammatory skin disease. While the etiology of psoriasis is not yet clear, environme-ntal factors such as food or eating habits are considered important aspects. Pine bark extract (Flavangenol Ⓡ ) is a polyphenol-rich antioxidant functional food material. Pine bark extract is known to have an anti-inflammatory effect, to protect and improve skin and blood vessels, and to improve hypercholesterolemia, and a high dose of pine bark extract improves psoriasis. In this study, we conducted a pilot clinical trial to evaluate the effect of pine bark extract on the skin condition and serum lipid levels of patients with psoriasis. Patients with mild to moderate psoriasis who are receiving continual and who gave informed were enrolled in this study. As a result, the Psoriasis Area Severity Index significantly decreased from 8.0±10.3 to 5.8±7.4 ( p <0.01). Total serum cholesterol level decreased to 208.1±29.6 from 216.8±24.2 ( p <0.05; as an observed analysis). Pine bark extract may improve the skin condition and serum total cholesterol level of psoriasis patients. The limitation of this study is a small sample size and open testing.","PeriodicalId":17355,"journal":{"name":"Journal of The Japan Organization of Clinical Dermatologists","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75967069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Condyloma acuminatum of the nipple resembling seborrheic keratosis 乳头尖锐湿疣类似脂溢性角化病

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.35

K. Murao, Y. Kubo

引用次数: 0

Analysis of 514 cases of the treatment of acute herpes zoster in the past 3 years: Relationship between the onset of postherpetic neuralgia and Amenalief® 400 mg 急性带状疱疹治疗3年来514例分析:amalief®400mg与疱疹后神经痛发病的关系

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.395

Toshitsugu Sato

引用次数: 0

Aggregation data of inpatients with onychomycosis in Akita National Hospital 秋田国立医院甲真菌病住院患者汇总资料

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.388

N. Maki, A. Ishida, T. Demitsu

引用次数: 0

Improved detection of the dermoscopic structures of pigmented mucosal lesions using high-dynamic-range image conversion 使用高动态范围图像转换改进皮肤镜下色素粘膜病变结构的检测

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2019-01-01 DOI: 10.3812/jocd.36.39

Toshitsugu Sato, Masaru Tanaka

引用次数: 0

A child with Henoch-Schönlein purpura successfully treated with diaphenyl sulfone 用二苯基砜成功治疗Henoch-Schönlein紫癜患儿

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2018-01-01 DOI: 10.3812/jocd.35.514

K. Shimizu, M. Kawase, T. Etoh

引用次数: 0

日本人尋常性乾癬患者に対するカルシポトリオール／ベタメタゾンジプロピオン酸エステルの配合ゲル剤の有効性および安全性の検討（国内第III相臨床試験）对日本普通银屑病患者使用钙三醇/倍他米松地丙酸酯配合凝胶剂的有效性及安全性的讨论(国内III期临床试验)

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2018-01-01 DOI: 10.3812/JOCD.35.51

Hidemi Nakagawa, Kazuo Isomae, T. Etoh

引用次数: 0

Clinical use of the topical nail liquid efinaconazole in 484 patients with onychomycosis including long-term cases. 外用依非那康唑甲液治疗甲癣484例。

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2018-01-01 DOI: 10.3812/jocd.35.748

M. Inami, A. Igarashi

{"title":"Clinical use of the topical nail liquid efinaconazole in 484 patients with onychomycosis including long-term cases.","authors":"M. Inami, A. Igarashi","doi":"10.3812/jocd.35.748","DOIUrl":"https://doi.org/10.3812/jocd.35.748","url":null,"abstract":"For the treatment of onychomycosis, only oral drugs and topical medications not specifically indicated for this disease were available until a specific topical drug was released. In September 2014, a topical drug for onychomycosis was first marketed in Japan (efinaconazole: Clenafin Ⓡ ), and clinical results concerning its use for one year or longer have not yet been reported. We investigated 484 patients who were prescribed efinaconazole for treatment of onychomycosis at our department. Among the patients in whom cure was achieved, treatment for one year or longer was required in more than 30%, and the overall cure rate was 14.9% in the actual clinical setting. Among all patients, 81.3% showed improvement to some extent (including cure). With regard to safety, there were no systemic adverse reactions, while contact dermatitis was observed in 13 out of 484 patients. The launch of efinaconazole, which causes fewer adverse reactions, has provided an option for patients who would not show an adequate response to conventional treatments. In particular, this drug can be a first-line treatment for elderly patients and those using multiple oral medications. However, good patient adherence is crucial for a successful outcome, as well as assiduous management by the physician at the time of treatment initiation. A detailed explanation about the realistic prospect of cure should also be provided.","PeriodicalId":17355,"journal":{"name":"Journal of The Japan Organization of Clinical Dermatologists","volume":"68 1","pages":"748-752"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81300837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

A case of bullous pemphigoid confined to umbilical region suspect of fixed drug eruption. 局限于脐部的大疱性类天疱疮1例，怀疑为固定药疹。

Journal of The Japan Organization of Clinical Dermatologists Pub Date : 2018-01-01 DOI: 10.3812/JOCD.35.610

M. Ota, Yoshie Ehara, S. Nishimoto, Yasuki Hata

引用次数: 0